Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy could stop prostate cancer spreading, trial shows

Posted by btwatson on June 2, 2018 9:14 pm
Tags:
Categories: Uncategorized

Source: Immunotherapy could stop prostate cancer spreading, trial shows

[unable to retrieve full-text content]

  1. Immunotherapy could stop prostate cancer spreading, trial shows  The Guardian
  2. Men with advanced prostate cancer could benefit from ‘amazing’ immunotherapy trial  ITV News
  3. Prostate cancer immune system drug results could be ‘spectacular’  BBC News
  4. Full coverage

Published at Sat, 02 Jun 2018 17:51:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • Imunon Inc (IMNN) Q3 2025 Earnings Call Highlights: Promising Advances in Immunotherapy and ... - Yahoo Finance
    November 13, 2025
  • CAR T REMS Elimination Eases Burden on Treatment Centers - Targeted Oncology
    November 13, 2025
  • Could adding a COVID-19 vaccination to immunotherapy lead to better outcomes for mesothelioma? - mesotheliomahelp.org
    November 13, 2025
  • Breast Cancer Biomarker Predicts Efficacy of Chemo and Immunotherapy - Inside Precision Medicine
    November 13, 2025
  • Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments - Business Wire
    November 13, 2025
  • Detalimogene Generates Improved, Compelling Efficacy Signals in NMIBC - Targeted Oncology
    November 13, 2025
  • Surgery After Immunotherapy Boosts Survival for Liver Cancer Patients - Mega Doctor News
    November 13, 2025
  • Resources for Community Oncologists on Specialized Immunotoxicity Management - Targeted Oncology
    November 13, 2025
  • Humanized Mice: Your Gateway to Predictive Immunotherapy Testing - Evotec
    November 13, 2025
  • The Importance of Lymph Nodes in Immunotherapy - AGEIST
    November 13, 2025

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com